{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:13:08Z","timestamp":1791180788900,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1856,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr. Blood Cancer"],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.1002\/pbc.22740","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T23:38:32Z","timestamp":1281915512000},"page":"1089-1095","source":"Crossref","is-referenced-by-count":33,"title":["Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells"],"prefix":"10.1002","volume":"55","author":[{"given":"Justus","family":"Lieber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Eicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Warmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Armeanu-Ebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,2]]},"reference":[{"key":"10.1002\/pbc.22740-BIB1|cit2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cncr.10632","article-title":"Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94","volume":"95","author":"Fuchs","year":"2002","journal-title":"Cancer"},{"key":"10.1002\/pbc.22740-BIB2|cit3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2","volume":"40","author":"Perilongo","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1002\/pbc.22740-BIB3|cit4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.22740-BIB4|cit5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1517\/14712590903136696","article-title":"Emerging gene-directed anti-tumor strategies against human hepatoblastoma","volume":"9","author":"Warmann","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"10.1002\/pbc.22740-BIB5|cit6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1432-2277.2008.00735.x","article-title":"Liver transplantation for primary and metastatic liver cancers","volume":"21","author":"Hoti","year":"2008","journal-title":"Transpl Int"},{"key":"10.1002\/pbc.22740-BIB6|cit7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1200\/JCO.2000.18.6.1279","article-title":"Feasibility and toxicity of chemoembolization for children with liver tumors","volume":"18","author":"Malogolowkin","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.22740-BIB7|cit8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pbc.21956","article-title":"Adenovirus-mediated cytosine deaminase\/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro","volume":"53","author":"Warmann","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.22740-BIB8|cit9","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1158\/1078-0432.CCR-08-2878","article-title":"Activation of phosphatidylinositol-3\u2032-kinase\/AKT signaling is essential in hepatoblastoma survival","volume":"15","author":"Hartmann","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.22740-BIB9|cit10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cancergencyto.2009.06.001","article-title":"Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas","volume":"194","author":"Stejskalova","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1002\/pbc.22740-BIB10|cit11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/138920109787315123","article-title":"Molecular targets for epigenetic therapy of cancer","volume":"10","author":"Humeniuk","year":"2009","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1002\/pbc.22740-BIB11|cit12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2008.08.002","article-title":"Mechanisms of proteasome inhibitor action and resistance in cancer","volume":"11","author":"McConkey","year":"2008","journal-title":"Drug Resist Update"},{"key":"10.1002\/pbc.22740-BIB12|cit13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2174\/156652409789839125","article-title":"Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours","volume":"9","author":"Marin","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1002\/pbc.22740-BIB13|cit14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"Kang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.22740-BIB14|cit15","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1038\/onc.2009.52","article-title":"Mimicking the BH3 domain to kill cancer cells","volume":"27","author":"Chonghaile","year":"2008","journal-title":"Oncogene"},{"key":"10.1002\/pbc.22740-BIB15|cit16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/mol.109.060780","article-title":"The BH3-mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs","volume":"77","author":"High","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1002\/pbc.22740-BIB16|cit17","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1158\/0008-5472.CAN-06-0367","article-title":"A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo","volume":"66","author":"Shoemaker","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.22740-BIB17|cit18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.humpath.2008.10.022","article-title":"Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways","volume":"40","author":"Adesina","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1002\/pbc.22740-BIB18|cit19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jss.2007.03.054","article-title":"Bcl-2 gene silencing in pediatric epithelial liver tumors","volume":"144","author":"Warmann","year":"2008","journal-title":"J Surg Res"},{"key":"10.1002\/pbc.22740-BIB19|cit20","first-page":"809","article-title":"Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma","volume":"74","author":"Pietsch","year":"1996","journal-title":"Lab Invest"},{"key":"10.1002\/pbc.22740-BIB20|cit21","first-page":"1","article-title":"Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma","volume":"67","author":"Doi","year":"1976","journal-title":"GANN"},{"key":"10.1002\/pbc.22740-BIB21|cit22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-230X(08)60912-4","article-title":"Criteria for analyzing interactions between biologically active agents","volume":"35","author":"Berenbaum","year":"1981","journal-title":"Adv Cancer Res"},{"key":"10.1002\/pbc.22740-BIB22|cit23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.critrevonc.2004.08.007","article-title":"Pharmacokinetic studies in children with cancer","volume":"52","author":"Groninger","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1002\/pbc.22740-BIB23|cit24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpedsurg.2008.10.088","article-title":"Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies","volume":"44","author":"Oue","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1002\/pbc.22740-BIB24|cit25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/08880010590964192","article-title":"Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma","volume":"22","author":"Warmann","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1002\/pbc.22740-BIB25|cit26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1002\/pbc.22740-BIB26|cit27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","article-title":"The role of Bcl-2 family members in tumorigenesis","volume":"1644","author":"Kirkin","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/pbc.22740-BIB27|cit28","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1158\/1078-0432.CCR-04-0908","article-title":"Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2\/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene-amplified breast cancer cells","volume":"10","author":"Milella","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.22740-BIB28|cit29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/1535-7163.MCT-05-0064","article-title":"A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells","volume":"4","author":"Yamanaka","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pbc.22740-BIB29|cit30","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/gut.2004.056192","article-title":"Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer","volume":"54","author":"Ocker","year":"2005","journal-title":"Gut"},{"key":"10.1002\/pbc.22740-BIB30|cit31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1002\/pbc.22740-BIB31|cit32","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1158\/1535-7163.MCT-08-0268","article-title":"ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo","volume":"7","author":"Ackler","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/pbc.22740-BIB32|cit33","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/sj.onc.1210028","article-title":"A novel Bcl-2\/Bcl-X(L)\/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma","volume":"26","author":"Chauhan","year":"2007","journal-title":"Oncogene"},{"key":"10.1002\/pbc.22740-BIB33|cit34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/pbc.21433","article-title":"Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing program","volume":"50","author":"Lock","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.22740-BIB34|cit35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1043805","article-title":"Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94","volume":"211","author":"Fuchs","year":"1999","journal-title":"Klin Padiatr"},{"key":"10.1002\/pbc.22740-BIB35|cit36","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1200\/JCO.2006.09.7204","article-title":"Redefining the role of doxorubicin for the treatment of children with hepatoblastoma","volume":"26","author":"Malogolowkin","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.22740","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.22740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:37:07Z","timestamp":1625398627000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.22740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,2]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.22740","relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,2]]}}}